Related Experiment Video
Updated: Feb 24, 2026
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
1.8K
Cancer Self-Defense: An Immune Stealth
Kosei Nakajima1, Pratima Nangia-Makker1, Victor Hogan1
1Department of Oncology, Karmanos Cancer Institute, School of Medicine, Wayne State University, Detroit, Michigan.
Cancer Research
|August 26, 2017
Summary
Tumor cells release decoy antigens, creating a "cancer-stealth" effect that hinders immunotherapy. Understanding the cancer secretome, including its components and exosomes, is crucial for improving cancer treatments and overcoming resistance.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Cancer immunotherapy faces challenges due to patient refractoriness and resistance.
- Tumor cells may evade immune detection by releasing anomalous antigens, termed a "decoy flare."
Purpose of the Study:
- To propose that the cancer secretome contributes to immune evasion and treatment resistance.
- To highlight the role of the cancer secretome in a "cancer-stealth" effect.
Main Methods:
- Analysis of the composition of the cancer secretome, including soluble macromolecules and exosomes.
- Conceptual framework linking secretome properties to immunotherapy outcomes.
Main Results:
- The cancer secretome comprises soluble macromolecules (proteins, glycans, lipids, DNAs, RNAs) and exosomes.
- This complex mixture can hinder the detection and recognition of cancer cells by immunotherapeutic agents.
- The secretome's properties contribute to a "cancer-stealth" phenomenon, promoting immune evasion.
Conclusions:
- Understanding the cancer secretome's properties is essential for advancing cancer immunotherapy.
- Evaluating the clinical significance of the cancer secretome may significantly alter therapeutic strategies.
- Targeting or understanding the secretome could overcome immunotherapy resistance and improve patient outcomes.
More Related Videos
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
02:40Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:27Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
01:51Mechanisms of Retrovirus-induced Cancers
7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K